Kelonia Therapeutics Archives

Wed. Apr 22nd, 2026

Eli Lilly makes a bold $3.25 billion acquisition of Kelonia Therapeutics, expanding its portfolio in biotech and cell therapies. What's driving this significant investment in cutting-edge medical research?

► Necessary Cookies Always Active

Necessary cookies enable essential site features like secure log-ins and consent preference adjustments. They do not store personal data.

► Functional Cookies Remark

Functional cookies support features like content sharing on social media, collecting feedback, and enabling third-party tools.

► Analytical Cookies Remark

Analytical cookies track visitor interactions, providing insights on metrics like visitor count, bounce rate, and traffic sources.

► Advertisement Cookies Remark

Advertisement cookies deliver personalized ads based on your previous visits and analyze the effectiveness of ad campaigns.

$3.25B Eli Lilly Deal: What’s Behind the Move?

You missed

India’s ₹500 Cr Grain Stockpile at Risk

Aishwarya Rai’s AI Avatar Goes Global

“Exclusive: Trump Calls Ceasefire Halt – 3 More Days of Talks?”

“Why Epstein’s Shadow Looms Over Warsh’s Fed Confirmation”

Tag: Kelonia Therapeutics